Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...
NEW ORLEANS, LA—For patients with atrial fibrillation (AF) who are at high risk of both stroke and bleeding, left atrial appendage occlusion (LAAO) isn’t noninferior to standard medical care including ...
In the PROTECT AF trial, patients randomized to left atrial appendage closure initially continued taking warfarin and aspirin to promote device endothelialization. At 45 days after the procedure, 86.8 ...
On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...
The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...
A Case of Isolated Minimally Invasive Hybrid Tricuspid Valve Replacement With Beating Heart and Cardiopulmonary Bypass for Secondary Tricuspid Regurgitation Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results